P03-024 – Early onset IBD treated by tocilizumab

نویسندگان

  • R Helbling
  • A Nyddeger
  • F Angelini
  • A Von Scheven Gete
  • M Hofer
چکیده

Introduction Inflammatory bowel diseases (IBD) normally manifest in adolescent and young adults; nevertheless, in about 1% of the cases, disease onset occurs before the 1 year of age. The clinical picture is often characterized by an indeterminate colitis whose clinical remission is difficult to achieve. Current treatment for IBD consists of either immunosuppressant or biological (Infliximab, Adalimumab) agents.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P03-012 - A P268S NOD2 mutation in one Blau patient

Introduction Blau syndrome (BS) is a rare autosomal dominant, autoinflammatory syndrome characterized by the clinical triad of granulomatous, recurrent uveitis, dermatitis and symmetric arthritis. The arthritis is usually a polyarticular exuberant synovitis and tenosynovitis and represents the characteristic phenotypic feature. Uveitis occurs in most patients and commonly evolves to a panuveiti...

متن کامل

IBD LIVE Case Series--Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.

LEARNING OBJECTIVES After completing this IBD LIVE-CME activity, physicians should be better able to: 1. Identify monogenic causes of early onset IBD. 2. Know when genetic testing might benefit the management of select IBD patients. 3. Be aware of potential clinical, endoscopic and histologic findings in early onset IBD. 4. Understand the pathophysiology and potential clinical course of IBD in ...

متن کامل

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping

BACKGROUND The inflammatory bowel diseases (IBD) are common, complex disorders in which genetic and environmental factors are believed to interact leading to chronic inflammatory responses against the gut microbiota. Earlier genetic studies performed in mostly adult population of European descent identified 163 loci affecting IBD risk, but most have relatively modest effect sizes, and altogethe...

متن کامل

Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease

Background. Tocilizumab, a monoclonal humanized anti-IL-6 receptor antibody, is used in treatment of refractory adult onset Still's disease (AOSD). Mild to moderate liver enzyme elevation is a well-known side effect, but severe liver injury has only been reported in 3 cases in the literature. Case. A young female suffering from corticoid and methotrexate refractory AOSD was treated by tocilizum...

متن کامل

Clinically inactive disease status with tocilizumab every 4 weeks in refractory systemic-onset juvenile idiopathic arthritis

Objective: Tocilizumab, an anti-IL-6 receptor antibody, was shown efficacious and safe in persistent systemic-onset juvenile idiopathic arthritis (SoJIA) when infused every 2 weeks, which generated financial burdens in developing countries. This study is to evaluate the curative effects of tocilizumab every 4 weeks (8 mg/kg) in the treatment of refractory SoJIA. Methods: This prospective interv...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 11  شماره 

صفحات  -

تاریخ انتشار 2013